Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma, Kaposi 2HIV Infections 2Acquired Immunodeficiency Syndrome 2

Interventions

Zidovudine 12Doxorubicin 11Vincristine 9Bleomycin 8Interferon alpha-2 6Methotrexate 5Leucovorin 5Dexamethasone 5Cyclophosphamide 5sargramostim 4Filgrastim 4Cytarabine 4Etoposide 3pomalidomide 2interferon alfa-n1 2Thalidomide 2Rituximab 2Isotretinoin 2Interleukin-2 2Didanosine 2Allopurinol 2tocilizumab 1plerixafor 1liposomal doxorubicin 1interferon gamma-1b 1abemaciclib 1Zalcitabine 1Vinblastine 1Valganciclovir 1Tumor Necrosis Factor-alpha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Acquired Immunodeficiency Syndrome × interferon alfa-n1 × Clear all
NCT00001113 2021-11-04

A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
48 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00000725 2021-11-03

A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
56 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡